Vicagrel 6mg

DRUG2 trials

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD

Conditions

Coronary Artery DiseaseHealthy SubjectsPK/PDPercutaneous Coronary InterventionPlatelet Aggregation Inhibitors

Phase 1

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

CompletedNCT03942458

Jiangsu vcare pharmaceutical technology co., LTDHealthy Subjects, PK/PD

Start: 2019-04-03End: 2019-09-03Updated: 2019-09-19

Phase 2

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

CompletedNCT03599284

Jiangsu vcare pharmaceutical technology co., LTDCoronary Artery Disease, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors

Start: 2018-08-30End: 2019-07-28Updated: 2019-09-23